NYSE: AGE - AgeX Therapeutics, Inc.

Rentabilité sur six mois: 0%
Rendement en dividendes: 0.00%
Secteur: Healthcare

Calendrier des promotions AgeX Therapeutics, Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise AgeX Therapeutics, Inc.

AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease.

plus de détails
Its lead small molecule drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation; and lead biologic candidate for induced tissue regeneration is AGEX-iTR1550 (Renelon), a gene delivery technology. AgeX Therapeutics, Inc. has a research collaboration with the University of California at Irvine to develop cellular therapies to treat neurological disorders and diseases. The company was incorporated in 2017 and is based in Alameda, California.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

IPO date 2018-11-29
ISIN US00848H1086
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.agexinc.com
Цена ао 11.1
Changement de prix par jour: 0% (11.1)
Changement de prix par semaine: 0% (11.1)
Changement de prix par mois: 0% (11.1)
Changement de prix sur 3 mois: 0% (11.1)
Changement de prix sur six mois: 0% (11.1)
Changement de prix par an: 0% (11.1)
Evolution du prix sur 3 ans: +1 253.66% (0.82)
Evolution du prix sur 5 ans: +1 329.86% (0.7763)
Evolution des prix depuis le début de l'année: 0% (11.1)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 2.98 6
P/BV 0.079 10
P/E 0 0
EV/EBITDA -0.4521 0
Total: 5.13

Efficacité

Nom Signification Grade
ROA, % -123.72 0
ROE, % -270.67 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -0.4441 10
Total: 9.6

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % -91.65 0
Rentabilité Ebitda, % -15.27 0
Rentabilité EPS, % 4028.55 10
Total: 2.6
Plus de détails

Établissements Volume Partager, %
Broadwood Capital, Inc. 2997156 7.9
Vanguard Group Inc 701755 1.85
Sigma Planning Corp 286425 0.75
Prescott General Partners LLC 185185 0.49
Bridgeway Capital Management, Inc. 144770 0.38
Geode Capital Management, LLC 140994 0.37
Blackrock Inc. 124301 0.33
Strategic Wealth Investment Group, LLC 97375 0.26
Creative Planning 70700 0.19
Northern Trust Corporation 31533 0.08



Superviseur Titre d'emploi Paiement Année de naissance
Ms. Eun-Jae Park CPA Chief Financial Officer 295.29k 1972 (53 année)
Dr. Ivan Labat Chief Information Officer N/A
Ms. Judith Segall Secretary N/A 1953 (72 année)

Adresse: United States, Alameda. CA, 1101 Marina Village Parkway - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.agexinc.com